Paradigm Biocapital Advisors LP: OCUL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on OCUL, newest first. How the timeline and the estimate are built.
Paradigm Biocapital Advisors LP held 0 OCUL shares at 2026-03-31 per its 13F-HR filed 2026-05-15.
the latest 13F is the newest step
- period ended2026-03-3113F 0 sharesChange vs previous 13F -2,935,284 shares
13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 2,935,284 sharesChange vs previous 13F -562,023 shares
0.95% of the 13F portfolio, value $35,634,348.
13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,497,307 sharesChange vs previous 13F +76,967 shares
1.21% of the 13F portfolio, value $40,883,519.
13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,420,340 sharesChange vs previous 13F +2,106,322 shares
1.36% of the 13F portfolio, value $31,740,755.
13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,314,018 sharesChange vs previous 13F not available
0.44% of the 13F portfolio, value $9,631,752.
13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).